MedTrace Logo

The Role of Surgery in Patients With Coronavirus Disease - 19 (COVID-19) Related Thoracic Complications

NCT05204537 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 83

Last updated 2023-05-30

No results posted yet for this study

Summary

Thoracic complications directly or indirectly consequence of Coronavirus Disease 2019 (COVID-19) (including either pathologies strictly related to the infection, or iatrogenic effects of therapeutic attempts to treat it) have been described during the pandemic.

Many of the above conditions often require a surgical approach but, based on published data reporting high early postoperative morbidity and mortality, many experts initially advised against any referral to surgery in COVID-19 patients.

Therefore, the issue is if salvage surgical approach should be always excluded or could be considered when it represents the only remaining effective option. In the absence of solid data and recommendations, this is a demanding challenge for thoracic surgeons.

The investigators have coordinated a multicenter study to collect the experience of several worldwide high-volume thoracic surgery departments. Their objective is to investigate efficacy and safety of surgery in COVID-19 patients who developed thoracic complications that required operative management.

Conditions

  • Surgical Complication
  • COVID-19
  • Pneumothorax
  • Empyema, Pleural
  • Abscess
  • Hemothorax
  • Thoracic

Interventions

PROCEDURE

Lung parenchyma resection

Lung parenchyma removal

PROCEDURE

Empyemectomy

Intrapleural cavity effusion removal, parietal pleura removal.

Sponsors & Collaborators

  • Azienda Ospedaliera San Gerardo di Monza

    collaborator OTHER

  • University of Milano Bicocca

    lead OTHER

Principal Investigators

  • Federico Raveglia, MD · ASST-Monza

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2021-05-31
Completion
2022-03-30

Countries

  • United States
  • Brazil
  • India
  • Italy
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05204537 on ClinicalTrials.gov